Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2025 Earnings Call Transcript March 12, 2026
Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.31, expectations were $-0.358.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Thursday, March 12, 2026. I would now like to turn the call over to Jennie Wilson. Please go...
